Proflazepam: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia talk: |
m Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot |
||
(15 intermediate revisions by 12 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
<!--Clinical data--> |
||
Line 16: | Line 19: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 52829-30-8 |
| CAS_number = 52829-30-8 |
||
| PubChem = 3050433 |
| PubChem = 3050433 |
||
Line 21: | Line 25: | ||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 545MN0F125 |
| UNII = 545MN0F125 |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 2312495 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=18 | H=16 | Cl=1 | F=1 | N=2 | O=3 |
| C=18 | H=16 | Cl=1 | F=1 | N=2 | O=3 |
||
| molecular_weight = 362.782 |
|||
| smiles = C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(CO)O |
| smiles = C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(CO)O |
||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C18H16ClFN2O3/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)21-8-17(25)22(16)9-12(24)10-23/h1-7,12,23-24H,8-10H2 |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = RCDQRWWSKKYAJG-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Proflazepam''' is a drug which is a [[benzodiazepine]] derivative.<ref>{{Cite journal |
'''Proflazepam''' ('''Ro10-3580''') is a drug which is a [[benzodiazepine]] derivative.<ref>{{Cite journal |title=LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY |journal=Official Journal of the European Communities |format=PDF |publisher=eur-lex.europa.eu |date=23 October 2001 |access-date=7 December 2009 |url=http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:279:0767:0876:EN:PDF }}</ref> |
||
⚫ | |||
==See also== |
==See also== |
||
*[[List of benzodiazepines]] |
|||
*[[Benzodiazepine]] |
|||
==References== |
==References== |
||
Line 39: | Line 47: | ||
{{Benzodiazepines}} |
{{Benzodiazepines}} |
||
{{GABAAR PAMs}} |
|||
⚫ | |||
[[Category:Benzodiazepines]] |
[[Category:Benzodiazepines]] |
||
[[Category: |
[[Category:Chloroarenes]] |
||
⚫ | |||
[[Category:Lactams]] |
[[Category:Lactams]] |
||
[[Category: |
[[Category:Fluoroarenes]] |
||
⚫ |